RUMORED BUZZ ON ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURERS

“The current situation has uncovered some structural weaknesses while in the EU’s medicines source chain along with a large dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides said. She advised that supply chain problems be resolved within an EU pharmaceutical technique anticipated being introduced by the tip of